330 related articles for article (PubMed ID: 32495220)
1. Prognostic Value of Blood-Based Inflammatory Biomarkers in Secondary Hemophagocytic Lymphohistiocytosis.
Huang J; Yin G; Duan L; Tian T; Xu J; Wang J; Gao X; Cheng W; Liu L; Qiu H
J Clin Immunol; 2020 Jul; 40(5):718-728. PubMed ID: 32495220
[TBL] [Abstract][Full Text] [Related]
2. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
3. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.
Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L
Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882
[No Abstract] [Full Text] [Related]
4. Prognostic factors of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children: report of the Japan Histiocytosis Study Group.
Kogawa K; Sato H; Asano T; Ohga S; Kudo K; Morimoto A; Ohta S; Wakiguchi H; Kanegane H; Oda M; Ishii E
Pediatr Blood Cancer; 2014 Jul; 61(7):1257-62. PubMed ID: 24535916
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of red blood cell distribution width, platelet distribution width, and red blood cell distribution width to platelet ratio in children with hemophagocytic lymphohistiocytosis.
Xi Y; Bai Y
J Clin Lab Anal; 2021 Sep; 35(9):e23909. PubMed ID: 34273201
[TBL] [Abstract][Full Text] [Related]
6. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
[TBL] [Abstract][Full Text] [Related]
7. Chronic active Epstein-Barr virus-associated secondary hemophagocytic lymphohistiocytosis in pregnancy: a case report.
Takahashi M; Makino S; Iizuka H; Noguchi M; Yoshida K
BMC Pregnancy Childbirth; 2021 Oct; 21(1):681. PubMed ID: 34620104
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis in Adults: A Retrospective Analysis of 23 Patients in China.
Shao X; Xu Y; Xu X; Xu Y; Chen H; Hong M; Liu L
Isr Med Assoc J; 2018 Feb; 20(2):80-85. PubMed ID: 29431300
[TBL] [Abstract][Full Text] [Related]
9. [Comparative Analysis of Primary and Reactivated EB Virus Infection Associated Hemophagocytic Lymphohistiocytosis].
Liu JH; Liu W; Li YG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):575-580. PubMed ID: 37096536
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features and outcome analysis of 83 childhood Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-2004 protocol].
Xiao L; Xian Y; Dai BT; Su YC; Xiao JW; Zheng QC; Zhao XD; Yu J
Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):668-72. PubMed ID: 22339824
[TBL] [Abstract][Full Text] [Related]
11. [Clinical Characteristics and Prognostic Analysis of 59 Adult Patients with Epstein-Barr Virus-Associated Hemophagocytic Syndrome].
Zhou YL; Li F; Zhang RY; Chen ZW; Zhong N; Tang WP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):657-662. PubMed ID: 32319412
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus central nervous system involvement in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Yin Q; Wang J; Wang Z
Ann Hematol; 2022 Nov; 101(11):2471-2476. PubMed ID: 36071294
[TBL] [Abstract][Full Text] [Related]
13. Clinical Characteristics of Hemophagocytic Lymphohistiocytosis Associated with Non-Hodgkin B-Cell Lymphoma: A Multicenter Retrospective Study.
Li B; Guo J; Li T; Gu J; Zeng C; Xiao M; Zhang W; Li Q; Zhou J; Zhou X
Clin Lymphoma Myeloma Leuk; 2021 Feb; 21(2):e198-e205. PubMed ID: 33303420
[TBL] [Abstract][Full Text] [Related]
14. [Characteristic and prognosis of patients with non-EBV infection-associated hemophagocytic lymphohistiocytosis].
You YH; Wang JS; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2022 Feb; 43(2):128-133. PubMed ID: 35381673
[No Abstract] [Full Text] [Related]
15. Treatment outcomes and prognostic factors for non- malignancy associated secondary hemophagocytic lymphohistiocytosis in children.
Pan H; Wang G; Guan E; Song L; Song A; Liu X; Yi Z; Sun LR
BMC Pediatr; 2020 Jun; 20(1):288. PubMed ID: 32517812
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China.
Li F; Yang Y; Jin F; Dehoedt C; Rao J; Zhou Y; Li P; Yang G; Wang M; Zhang R; Yang Y
Orphanet J Rare Dis; 2015 Feb; 10():20. PubMed ID: 25757854
[TBL] [Abstract][Full Text] [Related]
17. A predictive model for identifying secondary underlying diseases of hemophagocytic lymphohistiocytosis.
Gao WB; Hu LJ; Ma XL; Shi MJ; Wang CY; Ma Y; Song XJ; Zhu JH; Wang TB
Front Immunol; 2023; 14():1143181. PubMed ID: 37187741
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center.
Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z
Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156
[TBL] [Abstract][Full Text] [Related]
19. Viral etiology, clinical and laboratory features of adult hemophagocytic lymphohistiocytosis.
Chen J; Wang X; He P; Li Y; Si M; Fan Z; Chang X; Xie Q; Jiao X
J Med Virol; 2016 Mar; 88(3):541-9. PubMed ID: 26287378
[TBL] [Abstract][Full Text] [Related]
20. Secondary hemophagocytic lymphohistiocytosis in pediatric patients with visceral leishmaniasis and Epstein-Barr virus infection.
Li Y; Li S; Lu N; Wang W; Wang D
Ann Hematol; 2024 May; 103(5):1541-1547. PubMed ID: 38467825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
